Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT

XU Duo-rong; ZOU Wai-yi; XU Hui-ru; YANG Mao-hua

doi:10.3969/j.issn.1674-7445.2011.05.004

XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. DOI: 10.3969/j.issn.1674-7445.2011.05.004

Citation:

XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. DOI: 10.3969/j.issn.1674-7445.2011.05.004

Citation:

XU Duo-rong, ZOU Wai-yi, XU Hui-ru, et al. Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT[J]. ORGAN TRANSPLANTATION, 2011, 02(5): 253-256. DOI: 10.3969/j.issn.1674-7445.2011.05.004

Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Serum level of monocyte chemoattractant protein-2 cant be used as an indicator for identifying acute graft-versus-host disease or infection at the early stage after Allo-HSCT

Graphical Abstract

Catalog

Export File

Citation

Format

Content